Clinical Trials Directory

Trials / Completed

CompletedNCT01910051

Explorative Assessment of Biomarkers in Overweight and Obese Subjects

Explorative Assessment of Biomarkers Indicative of Insulin Resistance and Prediabetes in Overweight and Obese Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
106 (actual)
Sponsor
Profil Institut für Stoffwechselforschung GmbH · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The rationale for this trial is to apply a simple and minimally strenuous pre-screening approach prior to performing more extensive trial-specific screening and baseline-characterization activities in the resulting pre-selected population of subjects.

Detailed description

The pre-screening assessments are designed to characterize the metabolic risk profile / prediabetic status in an unselected population of overweight and obese volunteers, aiming to pre-select high risk and prediabetic subjects as a target population who may specifically profit from primary diabetes intervention (prevention) strategies.

Conditions

Timeline

Start date
2013-09-25
Primary completion
2021-12-23
Completion
2021-12-23
First posted
2013-07-29
Last updated
2021-12-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01910051. Inclusion in this directory is not an endorsement.